HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

dehydroxymethylepoxyquinomicin

an NF-kappaB inhibitor; structure in first source
Also Known As:
DHMEQ cpd
Networked: 41 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Umezawa, Kazuo: 34 articles (01/2014 - 01/2003)
2. Ozaki, Michitaka: 5 articles (01/2013 - 09/2008)
3. Todo, Satoru: 5 articles (01/2013 - 09/2008)
4. Miyajima, Akira: 4 articles (11/2013 - 04/2003)
5. Kikuchi, Eiji: 4 articles (11/2013 - 01/2003)
6. Horie, Ryouichi: 4 articles (01/2013 - 08/2005)
7. Umezawa, K: 4 articles (01/2013 - 07/2005)
8. Watanabe, Toshiki: 4 articles (04/2009 - 08/2005)
9. Oya, Mototsugu: 3 articles (11/2013 - 01/2003)
10. Horiguchi, Yutaka: 3 articles (04/2010 - 01/2003)

Related Diseases

1. Arthritis (Polyarthritis)
2. Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
3. Nephrosis
4. Neoplasms (Cancer)
5. Prostatic Neoplasms (Prostate Cancer)

Related Drugs and Biologics

1. NF-kappa B (NF-kB)
2. Cytokines
3. Puromycin Aminonucleoside
4. Integrins
5. Interleukin-6 (Interleukin 6)
6. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
7. epoxyquinomicin C
8. Osteoprotegerin
9. Reactive Oxygen Species (Oxygen Radicals)
10. Macrophage Colony-Stimulating Factor

Related Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Therapeutics